帕拉克瓦特 (除草剂) 作为帕金森病的原因
Priyanshu Sharma1, Payal Mittal1
1University Institute of Pharma Sciences, Mohali, Punjab, India.
Parkinsonism & related disorders
|November 26, 2023
概括
帕拉克瓦特暴露与帕金森病 (PD) 的发展有关. 这项研究总结了关于帕拉克瓦特如何在实验室模型中引起PD病理的研究,有助于发现新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 涉及运动症状,如勃拉迪基尼西亚和非运动症状.
- 病理学标志包括勒维体和多巴胺能神经元损失.
- 病理生理学是复杂的,涉及神经元亡与ER压力,氧化压力和线粒体功能障碍相关.
研究的目的:
- 总结帕拉克瓦特暴露与帕金森病发病之间的关系.
- 在体外和体外模型中审查帕拉克瓦特在创建PD病理特征中的作用.
- 突出帕拉克瓦特研究如何提高了对PD病理生理学和治疗点的理解.
主要方法:
- 对使用帕奎特模拟帕金森病的体外和体外研究进行审查.
- 对帕拉克瓦特与PD相关的神经毒性机制的分析.
- 检查流行病学数据,将帕拉克瓦特暴露与PD风险增加联系起来.
主要成果:
- 在动物模型中,暴露于Paraquat可以诱导帕金森病的各种病理特征.
- 流行病学研究表明,长期暴露在帕拉克瓦特和更高的PD发病率之间存在相关性.
- 帕拉奎特的特定神经毒性对了解PD病理生理学作出了重大贡献.
结论:
- 在研究环境中,Paraquat作为模拟帕金森病的宝贵工具.
- 了解帕拉克瓦和PD之间的联系为新的治疗策略开辟了道路.
- 对帕拉克瓦特诱导的神经退行症的进一步研究可以阐明PD机制.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
Anticholinesterase Agents: Poisoning and Treatment
877
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
877
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
157
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
157
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
303
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
303


